slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.240 KRW | +0,77% | +2,34% | -15,48% |
2023 | PharmGen Science, Inc. meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2022 | 151 mld. 110 mln. 103 mln. | Omzet 2023 | 167 mld. 121 mln. 113 mln. | Marktkapitalisatie | 111 mld. 80,96 mln. 75,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 70,06 mld. 50,93 mln. 47,64 mln. | Nettowinst (verlies) 2023 | 5,73 mld. 4,16 mln. 3,89 mln. | EV/omzet 2022 | 0,83 x |
Nettoschuld 2022 | 19,61 mld. 14,25 mln. 13,33 mln. | Nettoschuld 2023 | 526 mln. 382K 358K | EV/omzet 2023 | 0,67 x |
K/w-verhouding 2022 |
1,98
x | K/w-verhouding 2023 |
20,3
x | Werknemers | 250 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 86,72% |
1 dag | +0,77% | ||
1 week | +2,34% | ||
Lopende maand | -7,09% | ||
1 maand | -10,12% | ||
3 maanden | -11,93% | ||
6 maanden | -6,43% | ||
Lopend jaar | -15,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27-03-19 |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5.240 | +0,77% | 46 219 |
25-04-24 | 5.200 | -0,57% | 31 071 |
24-04-24 | 5.230 | +0,38% | 48 323 |
23-04-24 | 5.210 | +0,58% | 47 328 |
22-04-24 | 5.180 | +1,17% | 94 294 |
slotkoers Korea S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-15,48% | 68,67 mln. | |
+19,62% | 43,78 mld. | |
+20,44% | 21,89 mld. | |
+10,86% | 14,45 mld. | |
+13,07% | 13,63 mld. | |
+37,46% | 11,49 mld. | |
-8,59% | 6,85 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,06 mld. |